ID   HEV0139
AC   CVCL_T148
DR   CLO; CLO_0051270
DR   RCB; HEV0139
DR   Wikidata; Q54883031
RX   PubMed=16260175;
CC   Population: Japanese.
CC   HLA typing: A*02:06,26:01; B*40:02,54:01; C*01:02,03:04; DPB1*02:01,05:01; DQB1*03:03,06:02; DRB1*09:01,15:01 (RCB=HEV0139).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   23Y
CA   Transformed cell line
DT   Created: 03-02-14; Last updated: 29-06-23; Version: 10
//
RX   PubMed=16260175; DOI=10.1016/j.mrgentox.2005.07.012;
RA   Iwakawa M., Goto M., Noda S., Sagara M., Yamada S., Yamamoto N.,
RA   Kawakami Y., Matsui Y., Miyazawa Y., Yamazaki H., Tsuji H., Ohno T.,
RA   Mizoe J., Tsujii H., Imai T.;
RT   "DNA repair capacity measured by high throughput alkaline comet assays
RT   in EBV-transformed cell lines and peripheral blood cells from cancer
RT   patients and healthy volunteers.";
RL   Mutat. Res. 588:1-6(2005).
//